Work

Characterization of length-dependent GGAA-microsatellites in EWS/FLI mediated Ewing sarcoma oncogenesis

Year: 2018
Type: article
Abstract: Objective: Ewing Sarcoma is a pediatric bone malignancy initiated by a t(11;22) chromosomal translocation that produces the EWS/FLI oncoprotein.EWS/FLI transcriptionally activates and represses its target genes to mediate oncogenic reprogramming.Expression of its up-regulated targets correlates with EWS/FLI binding to associated GGAA-microsatellites, which show length polymorphisms.These microsatellite polymorphisms may critically affect EWS/FLI-responsiveness of key gene targets.For example, NR0B1 is necessary for EWS/FLI mediated oncogenic transformation, and we found a "sweet-spot" of 20-26 repeat length as optimal for EWS/FLI mediated transcriptional activity at NR0B1 through clinical observations and in vitro studies.The mechanism underlying this optimal length, however, is unknown.Methods: We explored the stoichiometry and binding affinity of EWS/FLI for different GGAA-repeat lengths through biochemical studies, including fluorescence polarization, ChIP-seq, and RNA-seq, combined with bioinformatics analysis.Additionally, use of EWS/FLI deletion constructs has been critical for elucidating the particular binding behavior of EWS/FLI at different microsatellite repeat lengths.Luciferase reporter assays, anchorage-independent growth and proliferation assays, as well as CRISPR technology have extended our findings to the in vivo setting.Finally, microscopy studies including use of confocal and transmission electron microscopy (TEM) have contributed visual characterization of the specific biochemical mechanisms we are investigating.iii Results: CRISPR-mediated deletion of the NR0B1 GGAA-microsatellite in Ewing sarcoma cells provided our field with the first in vivo evidence for the necessity of EWS/FLI binding at GGAA-microsatellites for anchorage dependent growth.Our biochemical studies, using recombinant Δ22 (a version of EWS/FLI containing only the FLI portion) demonstrate a stoichiometry of one monomer binding every two consecutive GGAA-repeats on shorter microsatellite sequences.Surprisingly, the affinity for Δ22 binding to GGAA-microsatellites significantly decreased, and was unmeasureable when the size of the microsatellite was increased to the "sweet-spot" length.In contrast, a fullyfunctional EWS/FLI mutant (Mut9, retaining approximately half of the EWS portion) showed low affinity for smaller GGAA-microsatellites, but instead significantly increased its affinity at "sweet-spot" microsatellite lengths.Single-gene ChIP and genome-wide ChIP-seq and RNA-seq studies extended these findings to the in vivo setting.Additionally, through bioinformatics analysis, we defined GGAA-microsatellites in a Ewing sarcoma setting, and showed GGAA-microsatellite length is predictive of EWS/FLI responsiveness (binding and transcriptional activation) at "promoter-like" EWS/FLI targets.Conclusion: Together, these data demonstrate the necessity for EWS/FLI binding at GGAA-microsatellites in Ewing sarcoma, and characterize their role in oncogenesis.These data also reveal an unexpected novel role for the EWS portion of the EWS/FLI fusion in DNA-binding.Overall, our results suggest a length-dependent biochemical mechanism for EWS/FLI binding and transcriptional regulation at GGAA-microsatellites. iv Dedication This work is dedicated to my family (Paul, Marianne, Quinn, Hayden, and Lauren Johnson), Randy Stokes, and my best friend Katelyn Sheffield, who encouraged me, put up with me,
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2892159642
FWCI:
Cites: 149
Cited by:
Related to: 10